Improved formulations of anti-cancer agents 5-Fluorouracil and Oxaliplatin using excipient technology [ 2008 - 2009 ]

Research Grant

Researchers: Prof Marie Ranson (Principal investigator) ,  Dr Craig Patch ,  Prof Philip Clingan ,  Tamantha Stutchbury

Brief description Chemotherapy plays a key role in cancer treatment, however, problems persist with severe adverse toxic effects. Combinations of anti-cancer agents give better results, but these agents still have major negative effects, for example, on veins and peripheral nerves and they must be given separately. We have developed a novel, all-in-one formulation of Oxaliplatin with 5-Fluorouracil and Leucovorin, with the potential for fewer toxic effects and improved patient care.

Funding Amount $AUD 202,973.00

Funding Scheme NHMRC Development Grants

Notes Development Grant